Budget 2021: UK GDP to return to pre-Covid levels by mid-2022
UK economy will experience ‘a swifter and more sustained recovery’ than previously predicted, according to OBR
Coronavirus
-
-
One year on: Funds that held up through the Covid sell-off
Six fund buyers highlight their best-performing holdings over the past year
-
FCA warns a quarter of UK adults have low financial resilience due to Covid
Financial Lives survey shows number of at risk Brits has shot up 15% since the start of the pandemic
-
Linden Thomson: It’s no surprise first vaccines came from biotech rather than large-cap pharma
Axa Framlington Biotech fund manager on vaccine makers thriving even after Covid
-
The three big themes dominating markets this year
Vaccine rollout, Joe Biden’s US and Brexit deal will be front of investors’ minds
-
How investors are playing the patchy rollout of Covid vaccines
‘The slow, uneven and multi-speed recovery will differ by sector and country’
-
Andrew Wolfson: Why Covid-19 should lead to a resurgence of entrepreneurship
The UK has a fine tradition of entrepreneurship and Covid-19 could even help spark the next generation of start-ups
-
How European fund managers avoided a disastrous 2020
The funds industry ended the year with €10trn in assets
-
Coronavirus weekly round-up: A highly controversial end to Trump’s tenure as the UK enters lockdown 3.0
Four investors mull the events shaping portfolios over the past week
-
FCA finds 4,000 firms at risk of failure due to Covid
Watchdog warns around 30% have ‘potential to cause harm’ if they closed down
-
Why the FTSE’s bumper start to 2021 could be short lived
Brexit deal and the rollout of the latest Covid vaccine saw the FTSE 100 rise 3%
-
Fund picks 2021: Tapping into a world with a Covid-19 vaccine
Will increasing immunisation levels continue to revive the fortunes of value investors?
